What I Am Reading
Monday, December 18, 2023
Markets
- It’s the Magnificent Seven’s Market. The Other Stocks Are Just Living in It.Wall Street Journal
- More Americans Than Ever Own StocksWall Street Journal
- Fed sparks irrational market optimism on possible rate cuts: Sheila BairCNBC
- Oil rises on Red Sea jitters, Russian export cutCNBC
- Record warmth leaves world with too much gasReuters
Global
- The Era of Big Taxes Is Upon UsWall Street Journal
Central banks
- Why Central Banks Should (but Might Not) Keep the Market Flooded With MoneyWall Street Journal
- Fed Chair Jerome Powell’s Pivot Is a Pretty Big GambleBloomberg
- Fed Official Says Central Bank Isn’t ‘Really Talking About Rate Cuts’Wall Street Journal
- The Fed Runs a Fool’s Errand on Bank Capital RulesBloomberg
- Federal Reserve President Searches Are Taking Months Longer Than BeforeBloomberg
- Elections may tweak sequencing of 2024 rate cutsReuters
US I
- The U.S. Debt Is Getting Uglier—And That's the PlanThe American Conservative
- Why U.S. ports are getting a $21 billion upgradeCNBC
- Why Immigration and Job Shortages Aren’t Two Separate ProblemsWall Street Journal
US II
- Home Buyers Are Ready to Buy. But Sellers Aren’t Selling.Wall Street Journal
- Office buildings could meet the same fate as shopping mallsCNN
- Generation Z Is Getting a Bad Deal on HousingManhattan Institute
- Here's why Gen Z women are confident they'll be ready for retirementCNBC
- The (Surprisingly) Good News on Life Expectancy: It’s Still Going UpWall Street Journal
Eurozone
- Eurozone Economic Activity Weakens for Seventh-Straight Month, PMIs ShowWall Street Journal
China
- China’s Economy Shows Signs of Losing Further MomentumWall Street Journal
- China’s Millionaires Are Worried. That’s a Problem for Wall Street.Wall Street Journal
Geopolitics & trade
Industries & companies
- Airlines:Southwest fined $140 million for last year's holiday meltdownCNBC
- Financials:Jamie Dimon’s Heir at JPMorgan Still Hazy as ‘Five More Years’ Tick ByBloomberg
- FinTech:How the Fintech Rally Could Fizzle in 2024Wall Street Journal
- Media:Meta's stock wrapping up record year, spurred by cost cutsCNBC
- Pharma:Weight loss drugs: 2024 expectations for Wegovy, Ozempic, ZepboundCNBC